Potential impact of hormonal male contraception: Cross-cultural implications for development of novel preparations

Human Reproduction

Volumn 15, Issue 3, 2000, Pages 637-645

  Martin, C W ^a   Anderson, R A ^a   Cheng, L ^b   Ho, P C ^b   Van Der Spuy, Z ^b   Smith, K B ^c   Glasier, A F ^c   Everington, D ^d   Baird, D T ^d  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Shanghai Institute of Family Planning Technical Instruction   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Acceptability; Attitudes; Cultural setting; Knowledge; Male contraception

Indexed keywords

MALE CONTRACEPTIVE AGENT;

ARTICLE; ATTITUDE; AWARENESS; CHINA; CONDOM; CULTURAL FACTOR; FAMILY PLANNING; HORMONAL CONTRACEPTION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; SEMEN ANALYSIS; SOUTH AFRICA; UNITED KINGDOM;

EID: 0034011741     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/15.3.637     Document Type: Article

References (19)

1. Bebb, R.A., Anawalt, B.D., Christensen, R.B. et al. (1996) Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach. J. din. Endocrinol. Metab., 81, 757-762.
2. Behre, H.M., Baus, S., Kleisch, S. et al. (1995) Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders. J. Clin. Endocrinol. Metab., 80, 2394-2403.
3. Davidson, A., Ahn, K.C., Chandra, S. et al. (1985) The acceptability of male fertility regulating methods: a multinational field survey. In Final Report to the Task Force on Psychosocial Research in Family Planning of the World Health Organization. World Health Organization, Geneva.
4. Drennam, M. (1998) Reproductive health: new perspectives on men's participation. Population Reports, Series J, no. 46.
5. Ezeh, A.C., Seroussi, M. and Raggers, H. ( 1996) Men ïFertility, Contraceptive Use, and Reproductive Preferences (DHS comparative studies no. 18). Macro International, Calverton, Maryland.
6. Glasier, A., Anakwe, R., Everington, D. et al. (2000) Would women trust their partners to use a male pill? Hum. Reprod., 15, 646-649.
7. Grady, W.R., Tanfer, K., Billy, J.O. and Lincoln-Hanson, J. (1996) Men's perceptions of their roles and responsibilities regarding sex, contraception and childrearing. Fain. Plan. Perspect., 28, 221-226.
8. Handelsman, D.J., Conway, A.J., Howe, C.J. et al. (1996) Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot. J. Clin. . Endocrinol. Melab.,81, 4113-4121.
9. Hulton, L. and Falkingham, J. (1996) Male contraceptive knowledge and practice: what do we know? Reprod. Health Matt., 7, 90-100.
10. ICPD; International Conference of Population and Development (1994) Programme of Action. United Nations, New York.
11. Keith, L., Keith, D., Bussell, R. and Wells, J. (1975) Attitudes of men toward contraception. Arch. Gynäkol., 220, 89-97.
12. Keller, A. (1979) Contraceptive acceptability research: utility and limitations. Stud. Fam. Plan., 10, 230-237.
13. Meriggiola, M.C. and Bremner, W.J. (1997) Progestin-androgen combination regimens for male contraception. J. Androl., 18, 240-244.
14. Potts, M. (1996) The myth of a male pill. Nature Med., 2, 398-399.
15. Ringheim, K. (1993) Factors that determine prevalence of use of contraceptive methods for men. Stud. Fam. Plan., 24, 87-99.
16. Ringheim, K. (1995) Evidence for the acceptability of an injectable hormonal method for men. Fam. Plan. Perspect., 27, 123-128.
17. Ringheim, K. (1996) Whither methods for men? Emerging gender issues in contraception. Reprod. Health Matt., 1, 79-89.
18. United Nations (1994) World Contraceptive Use 1994. UN Department for Economic and Social Information and Policy Analysis, Population Division, New York (ST/ESA/SER.A/143).
19. World Health Organization Task Force on Methods for the Regulation of Male Fertility (1996) Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil. Steril, 65, 821-829.